Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer
Ramez N. Eskander, MD, discusses overall survival data for pembrolizumab plus chemotherapy in advanced/recurrent endometrial cancer.
Source: onclive.com
Ramezn Eskander News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ramezn Eskander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ramezn Eskander Today - Breaking & Trending Today
Pembrolizumab Plus Chemo Could Represent a New SOC in Advanced/Recurrent Endometrial Cancer
Ramez N. Eskander, MD, discusses updated data for pembrolizumab plus chemotherapy in patients with advanced/recurrent endometrial cancer.
Source: onclive.com
Keytruda Combo Beneficial 'Irrespective of PD-L1' in Endometrial Cancer
Adding Keytruda to chemotherapy improved survival outcomes in patients with endometrial cancer, regardless of their mismatch repair or PD-L1 status.
Source: curetoday.com
FDA Grants Priority Review to Pembrolizumab Plus Chemotherapy in Endometrial Cancer
The sBLA for pembrolizumab plus chemotherapy in endometrial cancer has been granted priority review by the FDA.
Source: onclive.com
Treatment Breakthroughs: Immunotherapy Comes for Advanced Endometrial Cancer
Treatments for advanced endometrial cancer have progressed and improved with the use of immunotherapy with chemotherapy.
Source: curetoday.com